NXL — Nexalin Technology, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1527352 ·
Last close
$0.46
Market Cap
$9.92M
52W High
$0.64
52W Low
$0.31
ADV30
277,514
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 14,950 | 13,133 | -2,119,902 | -2,096,837 | 3,694,633 | 1,207,895 | 808,364 |
| Dec 2025 | 171,895 | 150,866 | -2,413,167 | -2,376,546 | 4,635,319 | 654,783 | 887,333 |
| Sep 2025 | 18,149 | 14,201 | -2,345,631 | -2,276,311 | 5,125,940 | 590,075 | 357,524 |
| Jun 2025 | 70,588 | 47,750 | -1,620,858 | -1,580,987 | 6,563,982 | 431,320 | 600,584 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,957,658
Investing CF
$-131,991
Financing CF
$5,039,734
CapEx
$-96,859
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.61
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-92,867,412
Inventory
$131,473
Receivables
$81,571
ST Investments
$3,068,429
EBIT TTM
$-8,390,881
Pretax Income TTM
$-8,221,133
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$275,582
EBITDA
$-8,471,964
Free Cash Flow
$-2,250,682
Enterprise Value
$6,594,419
Total Cash
$2,708,485
Total Debt
$0
Shares Out
21,540,662
Trailing EPS
$-0.46
Book Value
$0.14
ROE
-319.7%
ROA
-161.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 301,647 | -8,390,881 | -8,222,181 | 4,635,319 | 887,333 | — | -4,957,658 |
| Dec 2024 | 168,721 | -7,754,646 | -7,607,182 | 4,222,732 | 546,694 | — | -3,944,390 |
| Dec 2023 | 110,748 | -5,696,296 | -4,648,709 | 3,631,916 | 425,281 | — | -3,835,384 |
| Dec 2022 | 1,321,357 | -1,833,031 | -1,697,816 | 7,432,136 | 1,953,449 | — | -2,215,699 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.31
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CODX | Co-Diagnostics, Inc. | $9.55M | $2.61 | — |
| MBAI | Check-Cap Ltd | $9.43M | $1.22 | — |
| HSCS | HeartSciences Inc. | $9.02M | $2.74 | — |
| SINT | Sintx Technologies, Inc. | $10.94M | $1.72 | — |
| OSRH | OSR Health, Inc. | $11.53M | $0.33 | — |
News headlines (Yahoo Finance, 1h cache)
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
2026-06-23 12:30 · Yahoo
Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia
2026-06-16 13:15 · Yahoo
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Qu
2026-06-10 13:15 · Yahoo
EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life
2026-06-10 13:01 · Yahoo
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
2026-06-04 14:00 · Yahoo
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Vete
2026-05-21 12:30 · Yahoo
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
2026-05-19 12:30 · Yahoo
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
2026-04-28 13:15 · Yahoo
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
2026-04-22 13:35 · Yahoo
RedChip's Biotech Investor Conference Replays Now Available
2026-04-20 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.